Pharmaceutical companies competing to develop coronavirus vaccines are already working behind the scenes to build the supply chains necessary to deliver their drugs to billions of people as quickly as possible. To meet global demand once a vaccine is approved, a complicated and high-risk supply chain would be put in …
Read More »Pfizer shares rise after earnings. Here’s why stocks rose more.
Text size Spencer Platt / Getty Images Large pharmaceutical company Pfizer announced second-quarter financial results on Tuesday morning that exceeded Wall Street expectations, sending shares of around 3% in pre-trade. The company reported earnings of $ 0.78 per share, beating the FactSet consensus at $ 0.10 and the S&P Capital …
Read More »Pfizer CEO says companies should profit from Covid-19 vaccines
Text size Albert Bourla, CEO of the pharmaceutical company Pfizer Drew Angerer / Getty Images Albert Bourla, Pfizer‘s CEO, he has no patience with the argument that pharmaceutical companies should not make a profit from the drugs and vaccines they introduce to fight Covid-19. “I think it is very bad,” …
Read More »Moderna is asking for $ 60 for the Covid-19 vaccine, according to the report
Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »BioNTech COVID Vaccine Pfizer Enters Late-Stage Trial
Pfizer Inc. PFE, -0.31% and BioNTech SE BNTX, + 2.80% He said Monday night that they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, which involves 30,000 people worldwide. The start of the trial “is a great step forward in our progress towards the provision …
Read More »